ミトラマイシン

ミトラマイシン 価格 もっと(11)

メーカー	製品番号	製品説明	CAS番号	包装	価格	更新時間	購入
富士フイルム和光純薬株式会社(wako)	W01LKTM3476	ミトラマイシン Mithramycin	18378-89-7	1mg	￥18700	2024-03-01	購入
富士フイルム和光純薬株式会社(wako)	W01LKTM3476	ミトラマイシン Mithramycin	18378-89-7	5mg	￥74700	2024-03-01	購入
関東化学株式会社(KANTO)	41509-1A	ミトラマイシンＡ 90% Mithramycin A 90%	18378-89-7	5mg	￥103900	2024-03-01	購入
Sigma-Aldrich Japan	M6891	ミトラマイシンA from Streptomyces plicatus ≥90% (HPLC) Mithramycin A from Streptomyces plicatus ≥90% (HPLC)	18378-89-7	1mg	￥54900	2024-03-01	購入
Sigma-Aldrich Japan	M6891	ミトラマイシンA from Streptomyces plicatus ≥90% (HPLC) Mithramycin A from Streptomyces plicatus ≥90% (HPLC)	18378-89-7	5mg	￥133000	2024-03-01	購入

ミトラマイシン 化学特性,用途語,生産方法

効能

抗悪性腫瘍薬

説明

Mithramycin is an antineoplastic antibiotic produced by Streptomyces plicatus. It is well known as the aureolic acid antitumor antibiotic that inhibits both cancer growth and bone resorption by cross-linking GC-rich DNA, thus blocking binding of Sp-family transcription factors to gene regulatory elements. Transcription of c-Src, a gene implicated in many human cancers and required for osteoclast-dependent bone resorption, is regulated by the binding of Sp factors to specific elements in its promoter. Therefore, this gene represents an important anticancer target and a potential lead target through which mithramycin displays action against osteoclastic bone resorption via an unknown mechanism. Hazards of handling this drug by the health-care personnel arise from a combination of factors: (1) its inherent toxicity and (2) the extent to which workers are exposed to the drug in the course of carrying out their duties. This exposure may be through inadvertent ingestion of the drug on foodstuffs (e.g., workers’ lunches), inhalation of drug dusts or droplets, or direct skin contact. Mithramycin has been used to decrease bone resorption in patients with humoral hypercalcemia and Paget’s disease.

化学的特性

yellow powder

使用

Mithramycin was the first of the aureolic acid class of antitumour antibiotics, isolated from Streptomyces. Mithramycin inhibits transcription and protein synthesis by non-covalent binding with G-C-rich duplex DNA in the presence of magnesium and zinc ions. Mithramycin also induces differentiation of leukemic cells accompanied by an early decrease in c-myc expression, and selectively inhibits collagen-1 gene expression in human fibroblasts.

主な応用

Mithramycin, recently renamed plicamycin, was found in the culture broth of Streptomyces argillaceus and S. tanashiensis by Abbott Laboratories in 1952. It is structurally related to chromomycin A3. Mithramycin shows strong inhibitory activity against malignant cells of human origin. It acts by inhibition of the DNA-directed RNA synthesis through binding with DNA. Mithramycin is used intravenously to treat cancers of the embryonal cells, seminoma, choriocarcinoma, etc.

適応症

Plicamycin (mithramycin, Mithracin) is one of the chromomycin group of antibiotics produced by Streptomyces tanashiensis. Plicamycin binds to DNA and inhibits transcription. It also inhibits resorption of bone by osteoblasts, thus lowering serum calcium levels.Very little is known about its distribution, metabolism, and excretion. Because of its severe toxicity, plicamycin has limited clinical utility.The major indication for plicamycin therapy is in the treatment of life-threatening hypercalcemia associated with malignancy. Plicamycin also can be used in the palliative therapy of metastatic testicular carcinoma when all other known active drugs have failed.

一般的な説明

Chemical structure: aureolic acid

生物活性

Anticancer antibiotic that selectively binds to G-C-rich DNA in the presence of Mg 2+ or Zn 2+ , inhibiting RNA and DNA polymerase action. Inhibits c-myc expression and induces myeloid differentiation of HL-60 promyelocytic leukemia cells.

純化方法

Purify mithramycin A by crystallisation from CHCl3. It is soluble in MeOH, EtOH, Me2CO, EtOAc, Me2SO and H2O, and moderately soluble in CHCl3, but is slightly soluble in *C6H6 and Et2O. It is a fluorescent antitumour agent used in flow cytometry. [Thiem & Meyer Tetrahedron 37 551 1981, NMR: Yu et al. Nature 218 193 1968, Beilstein 17/1 V 672.]

ミトラマイシン 上流と下流の製品情報

原材料

準備製品

ミトラマイシン 生産企業

名前	電話番号	電子メール	国籍	製品カタログ	優位度
Hebei Mojin Biotechnology Co., Ltd	+8613288715578	sales@hbmojin.com	China	12456	58
career henan chemical co	+86-0371-86658258	sales@coreychem.com	China	29914	58
Hebei Guanlang Biotechnology Co., Ltd.	+86-19930503282	alice@crovellbio.com	China	8823	58
BOC Sciences	+1-631-485-4226	inquiry@bocsci.com	United States	19553	58
Chongqing Chemdad Co., Ltd	+86-023-61398051 +8613650506873	sales@chemdad.com	China	39916	58
Shaanxi Dideu Medichem Co. Ltd	+86-29-87569266 15319487004	1015@dideu.com	China	2263	58
Fuxin Pharmaceutical	+86-021-021-50872116 +8613122107989	contact@fuxinpharm.com	China	10297	58
SHANGHAI T&W PHARMACEUTICAL CO., LTD.	+86-021-61551413 +8618813727289	contact@trustwe.com	China	5738	58
Zhejiang Huida Biotech Co., LTD	008613515763466 8615669048680	wendy@huidabiotech.com	CHINA	87	58
HANGZHOU CLAP TECHNOLOGY CO.,LTD	86-571-88216897,88216896 13588875226	sales@hzclap.com	CHINA	6313	58

18378-89-7(ミトラマイシン)キーワード:

---

• 18378-89-7
• AUREOLIC ACID
• METHRAMYCIN A
• MITHRAMYCIN A, FOR FLUORESCENCE
• MITHRAMYCIN A FROM STREPTOMYCES*PLICATUS APPROX. 96
• MITHRAMYCIN COMPLEX FROM STREPTOMYCES*PL ICATUS
• MITHRAMYCIN FROM STREPTOMYCES PLICATUS
• MITHRACIN
• MITHRAMYCIN A
• MITHRAMYCIN A, STREPTOMYCES PLICATUS
• (2s-alpha,3beta(1r*,3r*4s*)))-droxy-7-methyl
• 1(2h)-anthracenone,6-((2,6-dideoxy-3-o-(2,6-dideoxy-beta-d-arabino-hexopyranos
• 6-dideoxy-alpha-d-lyxo-hexpyranosyl-(1-3)-2,6-dideoxy-beta-d-arabino-4)-o-2
• a-2371
• antibioticla7017
• aurelicacid
• aurlelicacid
• hexpyranosyl)oxy)-3-(3,4-dihydroxy-1-methoxy-2-oxopentyl)-3,4-dihydro-8,9-dihy
• nsc24559
• yl)-beta-d-arabino-h)-2-((o-2,6-dideoxy-3-c-methyl-beta-d-ribohexopyranosyl-(
• D-threo-2-Pentulose, 5-deoxy-1-C-(2S,3S)-7-2,6-dideoxy-3-O-(2,6-dideoxy-.beta.-D-arabino-hexopyranosyl)-.beta.-D-arabino-hexopyranosyloxy-3-(O-2,6-dideoxy-3-C-methyl-.beta.-D-ribo-hexopyranosyl-(1?3)-O-2,6-dideoxy-.beta.-D-lyxo-hexopyranosyl-(1?3)-2,6-did
• mithramycin a from streptomyces plicatus
• Mithramycin, Aureolic acid, Plicamycin
• Mithramycin A from Streptomyces argillaceus
• Aureolic acid, Plicamycin
• (2S-(2alpha,3beta(1R*,3R*,4S*)))-6-((2,6-Dideoxy-3-O-(2,6-dideoxy-beta-D-arabino-hexopyranosyl)-beta-D-arabino-hexopyranosyl)oxy)-2-((O-2,6-dideoxy-3-C-methyl-beta-D-ribo-hexopyranosyl-(1->4)-O-2,6-dideoxy-alpha-D-lyxo-hexopyranosyl-(1->3)-2,6-dideoxy-bet
• Mithramycin,90%
• Plicamycin(Mithramycin)
• (1S)-5-Deoxy-1-C-[(2S,3S)-7-[[2,6-dideoxy-3-O-(2,6-dideoxy-β-D-arabino-hexopyranosyl)-β-D-arabino-hexopyranosyl]oxy]-3-[(O-2,6-dideoxy-3-C-methyl-β-D-ribo-hexopyranosyl-(1.fwdarw.3)-O-2,6-dideoxy-β-D-lyxo-hexopyranosyl-(1.fwdarw.3)-2,6-dideoxy-β-D-arabino-hexopyranosyl)oxy]-1,2,3,4-tetrahydro-5,10-dihydroxy-6-methyl-4-oxo-2-anthracenyl]-1-O-methyl-D-threo-2-pentulose
• Plicamycin (50 mg)
• (1S)-5-Deoxy-1-C-[(2S,3S)-7-[[2,6-dideoxy-3-O-(2,6-dideoxy-β-D-arabino-hexopyranosyl)-β-D-arabino-hexopyranosyl]oxy]-3-[(O-2,6-dideoxy-3-C-Methyl-β-D-ribo-hexopyranosyl-(1.fwdarw.3)-O-2,6-dideoxy-β-D-lyxo-hexopyranosyl-(1.fwdarw.3)-2,6-dideo
• ミトラマイシン
• ミトラマイシンA
• ミスラマイシンA, PURE
• ミスラマイシンA
• ミトラマイシンA FROM STREPTOMYCES PLICATUS
• プリカマイシン
• (2S,3S)-6-[[2,6-ジデオキシ-3-O-(2,6-ジデオキシ-β-D-arabino-ヘキソピラノシル)-β-D-arabino-ヘキソピラノシル]オキシ]-2-[[3-O-[4-O-(2,6-ジデオキシ-3-メチル-β-D-ribo-ヘキソピラノシル)-2,6-ジデオキシ-α-D-lyxo-ヘキソピラノシル]-2,6-ジデオキシ-β-D-arabino-ヘキソピラノシル]オキシ]-3-[(1S,3S,4R)-3,4-ジヒドロキシ-1-メトキシ-2-オキソペンチル]-3,4-ジヒドロ-8,9-ジヒドロキシ-7-メチル-1(2H)-アントラセノン
• (2S,3S)-3-[(1S,3S,4R)-3,4-ジヒドロキシ-1-メトキシ-2-オキソペンチル]-2-{[(2S,4R,5R,6R)-4-{[(2R,4R,5R,6R)-5-{[(2S,4S,5R,6R)-4,5-ジヒドロキシ-4,6-ジメチルオキサン-2-イル]オキシ}-4-ヒドロキシ-6-メチルオキサン-2-イル]オキシ}-5-ヒドロキシ-6-メチルオキサン-2-イル]オキシ}-6-{[(2S,4S,5R,6R)-4-{[(2S,4R,5S,6R)-4,5-ジヒドロキシ-6-メチルオキサン-2-イル]オキシ}-5-ヒドロキシ-6-メチルオキサン-2-イル]オキシ}-8,9-ジヒドロキシ-7-メチル-1,2,3,4-テトラヒドロアントラセン-1-オン
• ミトラシン
• オーレオル酸
• (2S,3S)-3-[(1S,3S,4R)-3,4-ジヒドロキシ-1-メトキシ-2-オキソペンチル]-2-{[(2S,4R,5R,6R)-4-{[(2S,4R,5R,6R)-4-{[(2S,4S,5R,6R)-4,5-ジヒドロキシ-4,6-ジメチルオキサン-2-イル]オキシ}-5-ヒドロキシ-6-メチルオキサン-2-イル]オキシ}-5-ヒドロキシ-6-メチルオキサン-2-イル]オキシ}-6-{[(2S,4R,5S,6R)-4-{[(2S,4R,5S,6R)-4,5-ジヒドロキシ-6-メチルオキサン-2-イル]オキシ}-5-ヒドロキシ-6-メチルオキサン-2-イル]オキシ}-8,9-ジヒドロキシ-7-メチル-1,2,3,4-テトラヒドロアントラセン-1-オン
• (2S)-2β-[3-O-[3-O-(2,6-ジデオキシ-3-メチル-β-D-アロピラノシル)-2,6-ジデオキシ-β-D-グルコピラノシル]-2,6-ジデオキシ-β-D-グルコピラノシルオキシ]-6-[3-O-(2,6-ジデオキシ-β-D-グルコピラノシル)-2,6-ジデオキシ-β-D-ガラクトピラノシルオキシ]-3,4-ジヒドロ-8,9-ジヒドロキシ-3α-[(1S,3S,4R)-3,4-ジヒドロキシ-1-メトキシ-2-オキソペンチル]-7-メチルアントラセン-1(2H)-オン
• アウレオル酸
• ミスラマイシン